Fresh from sealing its maiden deal, GHO Capital is now looking to invest in more “mid-market, growing, profitable companies” within medtech, biopharma and B2B services.
The specialist healthcare private equity fund, established in 2014, announced Oct. 13 that it had acquired DNA Diagnostic Center (DDC),...





